{
    "code": 0,
    "data": [
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December 2025",
            "news_body": "Please find attached unaudited standalone and consolidated financial results for the year ended 31st December 2026",
            "news_id": "91f875c3-4b87-4b0c-8744-b63f597002d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=167c068f-1a60-47b0-8b17-eb30d9998667.pdf",
            "news_date": "2026-02-11 19:41:54",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30Th September 2025",
            "news_body": "We are hereby submitting the unaudited financial results for the quarter ended 30th September 2025",
            "news_id": "a6cfe1ee-659c-474f-9d58-d2bf7e47d6af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8560b609-928a-4099-8924-58d7fcadc3d1.pdf",
            "news_date": "2025-11-13 18:52:15",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter Ended 30Th June 2025",
            "news_body": "Financial Results for quarter ended 30th June 2025 approved by Board of Directors at their meeting held on 13th August 2025",
            "news_id": "6c8bce30-90b8-4d9c-bb87-7606fbc75bc7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61b3ebf8-616e-4a73-a1e8-31fc33323139.pdf",
            "news_date": "2025-08-13 19:05:42",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results",
            "news_body": "Approved and Considered audited standalone and consolidated financial results for the quarter ended 31st March 2025",
            "news_id": "e4ed27b5-8b2f-44c4-8d5d-54abd0dfbdf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a426f9dd-1a32-4164-9f7b-0594baf153c6.pdf",
            "news_date": "2025-05-19 21:31:45",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Considered And Approved Unaudited Financial Result For December 31 2024",
            "news_body": "Considered and Approved unaudited financial results for quarter ending 31st December 2024",
            "news_id": "ab857a86-015d-4e9a-a933-68e7bf708e69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1088269c-4fa2-4401-a77e-c344e14c6aa8.pdf",
            "news_date": "2025-02-11 18:23:24",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2024",
            "news_body": "We are submitting herewith the financial results for the quarter ended 30th September, 2024",
            "news_id": "9abe0173-0069-4f5a-8ca8-4ee2df6d6126",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e78b54a-c619-4173-aa47-ee502c84c1a1.pdf",
            "news_date": "2024-11-12 18:32:39",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Financial Results For The Quarter Ended 30Th June, 2024",
            "news_body": "Submission of Standalone and Consolidated Results for the quarter ended 30th June, 2024",
            "news_id": "cdf51bf1-6ce8-4e25-94f4-c41ccee0efaf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26395e63-0278-48e0-b172-24320a46e7cd.pdf",
            "news_date": "2024-08-08 18:24:57",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Submission of Transcript of Earning Call",
            "news_id": "5a6e64f6-f1a0-41a7-8d56-2ff0e2c2ee43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c02771e-7374-416f-967b-7a5f0d228187.pdf",
            "news_date": "2024-06-14 12:04:17",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of earning call",
            "news_id": "d7ee7bd9-1442-41b0-92ec-f8ca68c88f22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b4a6b60-31fb-4b19-80e1-5377ea32439a.pdf",
            "news_date": "2024-06-10 14:16:35",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Year Ended 31St March 2024",
            "news_body": "Financial Results for the year ended 31st March, 2024",
            "news_id": "03dc4af9-f6b6-4bcc-87f6-0e77de2b55b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=556c1823-56e6-4ace-8af4-fa98f8cfd6ee.pdf",
            "news_date": "2024-05-27 19:21:47",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Submission of financial results for the quarter ended 31st December, 2023",
            "news_id": "d4415d6a-605e-44cc-a73b-3647e241be2e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56ac2179-e4fb-49c6-9b4e-ab2b92f7f0a1.pdf",
            "news_date": "2024-02-08 18:06:14",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2023",
            "news_body": "Declaration of Financial Results for the quarter ended 31st December, 2023",
            "news_id": "acc6f77b-7e78-4b9c-b1a3-64cb68abd050",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cda068d-fec8-498e-b33d-a67e4ed73353.pdf",
            "news_date": "2024-02-08 18:00:00",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2023",
            "news_body": "Enclosed please find Financial Results for the quarter ended 30th September, 2023",
            "news_id": "9680b137-48e7-46a0-9869-bec04ad7e8b1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fe11231-7c4a-4d96-9338-ab34764d2c1a.pdf",
            "news_date": "2023-11-09 18:45:56",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Considered And Approved Unaudited Financials Results For The Quarter Ended 30Th June, 2023",
            "news_body": "Considered and approved financial results for the quarter ended 30th June, 2023",
            "news_id": "a8fa2880-91c9-463f-8c19-d98a80e39a22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6bd4fde-7e4d-4ff8-8820-3ba7712486b7.pdf",
            "news_date": "2023-08-11 13:55:40",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Conference Call",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, further to our intimation dated 29th May, 2023 regarding earnings call, the audio recording of the call held today i.e. Friday, 2nd June, 2023 is available on our website. The same can be accessed through below link:https://kilitch.com/wp-content/uploads/2023/06/Kilitch-Drugs-India-Limited-Q4-FY23-Concall-Audio.mp3",
            "news_id": "87422cf1-1a67-4944-98b1-15417b8715da",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69db9cbe-f57a-4e31-a5dc-528ac3f3536c.pdf",
            "news_date": "2023-06-02 17:13:22",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31St March, 2023",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e. 29th May, 2023 have considered and approved the following; 1. Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2023. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference.2. Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2023.",
            "news_id": "ce8ba6cf-fa16-41f2-93ef-f7971c8383f6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a40e34c5-df65-449c-abeb-3f6c6f91c15f.pdf",
            "news_date": "2023-05-29 18:09:56",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 31St December, 2022",
            "news_body": "Financial Results for the quarter ended 31st December, 2022",
            "news_id": "5a67b66b-06c1-478e-8423-c72d08084a28",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735c0c49-ec6e-46a6-8cae-5f2924d8aeaf.pdf",
            "news_date": "2023-02-14 18:02:39",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2022, Pursuant To Regulation 23(9) Of Tile SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions of the Company for the half-year ended 30th September, 2022.",
            "news_id": "6912f7ad-beac-407f-805c-7fd528314446",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67b8e1a0-a7af-46ff-aec1-ad0a1e3a1ca4.pdf",
            "news_date": "2022-11-28 16:23:08",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30Th September, 2022",
            "news_body": "In continuation of our letter dated 3rd November, 2022 and pursuant to Regulation 30 and Regulation 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby would like to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, 14th November, 2022 have considered and approved the following;<BR> <BR> 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September, 2022. The copy of Unaudited Financial Results (Standalone and Consolidated) as considered and approved by the Board of Directors along with Limited Review Report by the Auditors are enclosed herewith for your ready reference.<BR>",
            "news_id": "5614c67e-79d9-4b7c-8c8b-d5abfd3ec533",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cb5bc07-a87a-4d53-8a13-2e6b05554372.pdf",
            "news_date": "2022-11-14 19:10:14",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Consideration And Approval Of Financial Results",
            "news_body": "Board of Directors approved unaudited financial results for the quarter ended 30th June, 2022. approved the appointment of Cost Auditor. Approved Notice of 30th Annual General Meeting of the Company and fixed the date of the same.",
            "news_id": "3ebc60f2-32f3-4828-a24e-18f9676d4f7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=05e802c4-2179-4bdb-afd4-17b5407304ce.pdf",
            "news_date": "2022-08-10 18:31:09",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended 31St March, 2022, Pursuant To Regulation 23(9) Of Tile SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions of the Company for the half-year ended 31st March, 2022",
            "news_id": "2a4d63a6-5223-42af-a96d-3c87091674a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75695ab9-21a9-4bdb-83e3-c700af9948f8.pdf",
            "news_date": "2022-06-08 16:14:36",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Year Ended 31.03.2022",
            "news_body": "Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,we hereby would like to inform you that Board of Directors of the Company, at its meeting held today i.e.26th May, 2022, have considered and approved the following; <BR> <BR> 1.Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2022. The copy of Audited Financial Results (Standalone and Consolidated) as adopted and approved by the Board of Directors and Auditor''s report thereon are attached herewith for your ready reference.<BR> <BR> 2.Pursuant to Regulation 33(3)(d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby declare that the Statutory Auditors of the Company have issued their audit reports with unmodified (i.e., unqualified) opinion on the Financial Statements (Standalone and Consolidated) for the year ended on 31st March, 2022.<BR> <BR> <BR>",
            "news_id": "2c1ca8c3-21b3-4b29-a451-883f357567eb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7397b4e-5e95-47ac-b001-efba55a526f0.pdf",
            "news_date": "2022-05-26 18:16:29",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of The Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2021;",
            "news_body": "In continuation to our letter dated 7th February 2022, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 14th February, 2022, have -<BR> <BR> 1.Considered and approved the Un-audited financial results of the company for the quarter ended 31st December 2021;<BR> <BR> In this connection please find enclosed the copy of Un-audited Standalone & Consolidated financial Results of the Company for the quarter ended 31st December 2022 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'.  <BR> <BR> The meeting commenced at 04: 00 P.M. and concluded at 07:00 P.M.<BR> <BR> The above is for information and dissemination to the public at large.",
            "news_id": "7c394f06-80ff-4441-bee9-00c78ad6f695",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fac39b65-89f3-4e4b-a314-19ba0d7c8576.pdf",
            "news_date": "2022-02-14 19:05:23",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Approval Of The Un-Audited Financial Results Of The Company For The Quarter Ended 31St December 2021;",
            "news_body": "In continuation to our letter dated 7th February 2022, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 14th February, 2022, have -<BR> <BR> 1.Considered and approved the Un-audited financial results of the company for the quarter ended 31st December 2021;<BR> <BR> In this connection please find enclosed the copy of Un-audited Standalone & Consolidated financial Results of the Company for the quarter ended 31st December 2022 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'.  <BR> The meeting commenced at 04: 00 P.M. and concluded at 07:00 P.M.<BR> <BR> The above is for information and dissemination to the public at large.<BR>",
            "news_id": "7c719ab8-2f8c-49fa-9171-6d1fc4ddf12d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b66a6915-9e92-49c7-807b-d134ebf744cc.pdf",
            "news_date": "2022-02-14 19:00:26",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 30th  September, 2021, in the format specified on the relevant accounting standards.",
            "news_id": "33ff1a2b-b938-4658-9b2d-4b1c38ff42a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c14cbeca-3f3e-4034-ac76-7afe638755d0.pdf",
            "news_date": "2021-11-30 14:37:27",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "In continuation to our letter dated 2nd November 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 12th November, 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter and half year ended 30th September 2021;",
            "news_id": "81ce382f-dbbc-4983-a344-3322a048e2a8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6149cf93-ada7-49ad-81d9-d6be3de58182.pdf",
            "news_date": "2021-11-12 19:48:37",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "In continuation to our letter dated 2nd November 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 12th November, 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter and half year ended 30th September 2021;",
            "news_id": "46708a19-b171-4750-b176-ad12af26524b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8d77788-a4b4-450d-8b56-cb95bd9560f4.pdf",
            "news_date": "2021-11-12 19:48:04",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November, 2021",
            "news_body": "In continuation to our letter dated 2nd November 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 12th November, 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter and half year ended 30th September 2021;<BR>",
            "news_id": "57d3343b-3c07-431a-aed8-b0ce7a23d92d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86d4d732-3757-4f26-82dc-c76acca856af.pdf",
            "news_date": "2021-11-12 19:42:53",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On 13Th August 2021",
            "news_body": "In continuation to our letter dated 5th August 2021, we wish to inform you that pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company, at its meeting held today i.e. 13th August 2021, have considered and approved the following-<BR> <BR> 1.The Un-audited financial results of the company for the quarter ended 30th June 2021;<BR> <BR> In this connection please find enclosed the copy of Un-audited Standalone financial Results of the Company for the quarter ended 30th June 2021 along with Limited Review Report by the Statutory Auditors of the Company as 'Annexure-I'.  <BR> <BR> 2.The appointment of M/s Suryaprakash Maurya & Co (FRN: 147410W) as the Statutory Auditor of the Company to hold office from the conclusion of 29th AGM till the conclusion of 34th AGM.",
            "news_id": "9ac0dbf5-3636-428c-89e8-1dd194455982",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cc7c8f7-e1d3-49c3-a9e3-1ac8fc78bf74.pdf",
            "news_date": "2021-08-13 17:09:34",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transaction Pursuant To Regulation 23(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of Related Party Transaction on consolidated basis for the half year ended 31st March 2021, in the format specified on the relevant accounting standards.",
            "news_id": "bc893443-d710-49e6-92fa-82bb1bb0a041",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=39a9a59c-1d2d-492c-9901-1097974cc71d.pdf",
            "news_date": "2021-07-08 16:28:46",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "KILITCH",
            "disp": "Kilitch Drugs",
            "bse_code": 524500,
            "isin": "INE729D01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting - Financial Results For The Quarter And Year Ended 31St March, 2021",
            "news_body": "We enclosed herewith the audited standalone and consolidated financial results of the Company for the quarter and year ended 31st March, 2021, which have been approved and taken on record at the meeting of the Board of Directors of the Company held today, i.e. 22nd June, 2021.<BR> <BR> Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we would like to confirm that M/s. A.M. Ghelani & Co., Chartered Accountants (Firm Registration no. 103173W)), Statutory Auditors of the Company, have issued Audit Reports with unmodified opinion on the above financial results.<BR> <BR> The meeting of Board of Directors held today commenced at 4:00 PM and concluded at 5:35 PM.",
            "news_id": "f3b364f8-3089-4bcb-9efe-586f0f1c88dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c435cbdf-68ea-44f0-b12f-f570c62b5b2b.pdf",
            "news_date": "2021-06-22 18:07:01",
            "seo": "kilitch-drugs-ltd",
            "ltp": 366.05,
            "ch": -2.8000000000000114,
            "pch": -0.7591161718855934,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19937,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}